1. Home
  2. ADXN vs GSIW Comparison

ADXN vs GSIW Comparison

Compare ADXN & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • GSIW
  • Stock Information
  • Founded
  • ADXN 2002
  • GSIW 2016
  • Country
  • ADXN Switzerland
  • GSIW Hong Kong
  • Employees
  • ADXN N/A
  • GSIW N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • GSIW
  • Sector
  • ADXN Health Care
  • GSIW
  • Exchange
  • ADXN Nasdaq
  • GSIW Nasdaq
  • Market Cap
  • ADXN 8.0M
  • GSIW 12.3M
  • IPO Year
  • ADXN N/A
  • GSIW 2023
  • Fundamental
  • Price
  • ADXN $7.59
  • GSIW $0.79
  • Analyst Decision
  • ADXN Strong Buy
  • GSIW
  • Analyst Count
  • ADXN 1
  • GSIW 0
  • Target Price
  • ADXN $30.00
  • GSIW N/A
  • AVG Volume (30 Days)
  • ADXN 24.6K
  • GSIW 11.3M
  • Earning Date
  • ADXN 03-24-2025
  • GSIW 12-31-2024
  • Dividend Yield
  • ADXN N/A
  • GSIW N/A
  • EPS Growth
  • ADXN N/A
  • GSIW N/A
  • EPS
  • ADXN 0.06
  • GSIW N/A
  • Revenue
  • ADXN $701,260.00
  • GSIW $1,313,795.00
  • Revenue This Year
  • ADXN N/A
  • GSIW N/A
  • Revenue Next Year
  • ADXN N/A
  • GSIW N/A
  • P/E Ratio
  • ADXN $1.04
  • GSIW N/A
  • Revenue Growth
  • ADXN N/A
  • GSIW N/A
  • 52 Week Low
  • ADXN $6.81
  • GSIW $0.43
  • 52 Week High
  • ADXN $27.90
  • GSIW $15.45
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • GSIW 64.32
  • Support Level
  • ADXN $7.20
  • GSIW $0.44
  • Resistance Level
  • ADXN $8.04
  • GSIW $0.51
  • Average True Range (ATR)
  • ADXN 0.51
  • GSIW 0.11
  • MACD
  • ADXN 0.00
  • GSIW 0.01
  • Stochastic Oscillator
  • ADXN 47.95
  • GSIW 43.39

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: